Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-01 Sale | 2024-11-01 5:57 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,546 | $24.28 | $86,083 | 33,724 (Direct) | View |
| 2024-10-30 Sale | 2024-10-30 8:30 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,368 | $24.3 | $57,554 | 101,201 (Direct) | View |
| 2024-08-26 Sale | 2024-08-26 5:41 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 20,000 | $25.22 | $504,370 | 31,002 (Direct) | View |
| 2024-08-01 Sale | 2024-08-01 7:06 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,477 | $21.45 | $74,576 | 51,002 (Direct) | View |
| 2024-07-30 Sale | 2024-07-30 7:06 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,490 | $20.67 | $51,463 | 127,046 (Direct) | View |
| 2024-06-20 Sale | 2024-06-20 4:58 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 20,000 | $20.01 | $400,216 | 48,333 (Direct) | View |
| 2024-05-02 Sale | 2024-05-02 6:01 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,499 | $12.83 | $44,878 | 68,333 (Direct) | View |
| 2024-04-30 Sale | 2024-04-30 6:33 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 1,387 | $12.04 | $16,703 | 108,035 (Direct) | View |
| 2024-02-16 Sale | 2024-02-16 7:20 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 6,812 | $10.02 | $68,223 | 68,333 (Direct) | View |
| 2024-01-30 Sale | 2024-01-30 6:53 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 1,671 | $7.9902 | $13,352 | 116,234 (Direct) | View |
| 2023-12-20 Sale | 2023-12-21 5:19 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,541 | $10 | $35,421 | 71,930 (Direct) | View |
| 2023-12-19 Sale | 2023-12-20 4:55 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 10,906 | $10 | $109,093 | 75,471 (Direct) | View |
| 2023-10-31 Sale | 2023-11-01 4:41 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 1,080 | $5.1974 | $5,613 | 132,352 (Direct) | View |
| 2023-07-31 Sale | 2023-08-01 4:28 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 1,245 | $9.6547 | $12,020 | 133,432 (Direct) | View |
| 2023-05-01 Sale | 2023-05-02 4:33 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 721 | $9.8763 | $7,121 | 110,677 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 4:17 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 924 | $11.78 | $10,884 | 111,398 (Direct) | View |
| 2022-10-31 Sale | 2022-11-01 7:35 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 739 | $12.88 | $9,519 | 112,322 (Direct) | View |
| 2022-08-01 Sale | 2022-08-02 5:46 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 752 | $15.67 | $11,784 | 113,061 (Direct) | View |
| 2022-05-02 Sale | 2022-05-03 7:03 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 697 | $11.75 | $8,190 | 45,480 (Direct) | View |
| 2021-02-24 Sale | 2021-02-25 4:18 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 35,419 | $39.9 | $1,413,218 | 65,667 (Direct) | View |
| 2021-02-22 Sale | 2021-02-23 6:04 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 5,330 | $39.93 | $212,839 | 97,753 (Direct) | View |
| 2021-02-18 Sale | 2021-02-22 4:09 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 13,583 | $35.46 | $481,621 | 69,750 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-30 Exercise | 2024-10-30 8:30 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,636 | $0 | 101,201 (Direct) | View |
| 2024-07-30 Exercise | 2024-07-30 7:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,636 | $0 | 127,046 (Direct) | View |
| 2024-04-30 Exercise | 2024-04-30 6:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,886 | $0 | 108,035 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 07:23 am | N/A 2034-02-12 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-01-30 Exercise | 2024-01-30 6:53 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,886 | $0 | 116,234 (Direct) | View |
| 2023-10-30 Exercise | 2023-11-01 4:41 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,886 | $0 | 132,352 (Direct) | View |
| 2023-07-30 Exercise | 2023-08-01 4:28 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,886 | $0 | 133,432 (Direct) | View |
| 2023-04-30 Exercise | 2023-05-02 4:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,886 | $0 | 110,677 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-15 4:13 pm | N/A 2033-02-13 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 112,900 | $0 | 112,900 (Direct) | View |
| 2023-01-30 Exercise | 2023-02-01 4:17 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,886 | $0 | 111,398 (Direct) | View |
| 2022-10-30 Exercise | 2022-11-01 7:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,886 | $0 | 112,322 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-10 4:17 pm | N/A 2032-08-08 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2022-07-30 Exercise | 2022-08-02 5:46 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,886 | $0 | 113,061 (Direct) | View |
| 2022-05-31 Exercise | 2022-06-01 4:57 pm | N/A 2026-04-26 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 68,333 | $0 | 70,522 (Direct) | View |
| 2022-05-31 Exercise | 2022-06-01 4:57 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 68,333 | $0.84 | 70,522 (Direct) | View |
| 2022-04-30 Exercise | 2022-05-03 7:03 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,886 | $0 | 45,480 (Direct) | View |
| 2022-01-19 Option Award | 2022-01-21 4:16 pm | N/A 2032-01-18 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 150,071 | $0 | 150,071 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-25 4:18 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 1,829 | $7.26 | 65,667 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-25 4:18 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 20,393 | $1.2 | 65,667 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-25 4:18 pm | N/A 2028-03-01 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 35,419 | $0 | 65,667 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-25 4:18 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 13,197 | $1.86 | 65,667 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-23 6:04 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,913 | $1.2 | 97,753 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-23 6:04 pm | N/A 2026-04-26 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 5,330 | $0 | 97,753 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-23 6:04 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 1,417 | $0.84 | 97,753 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 4:09 pm | N/A 2026-01-27 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 13,583 | $0 | 69,750 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 4:09 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 13,583 | $0.84 | 69,750 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-12 7:27 pm | N/A 2031-02-10 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2020-07-23 6:46 pm | N/A 2028-03-01 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 0 | $0 | 271,665 (Direct) | View |